NVIDIA Announces Agentic AI Vision at J.P. Morgan Healthcare Conference, Partners with IQVIA

By Allison Proffitt 

January 13, 2025 | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.  

In a private press briefing last week, Kimberly Powell, VP of Healthcare at NVIDIA, cast NVIDIA’s vision for the AI Industrial Revolution and outlined the computing advancements that are enabling it.   

For the first half of the last century, computing was done by humans, she explained. Compute code was written as serial instructions because that’s how humans think. But that has changed as large language models became the operating system of the computer.  

Gone are the innovations of perceptive AI and generative AI, Powell said. AI is “very rapidly accelerating into agentic AI,” she said, AI that acts as an agent, not only perceiving, but reasoning, planning, and even taking action and performing tasks.” AI agents can use tools (tool calling), choose from accessible information, and collaborate with humans. “Agents are becoming, you could imagine them, digital employees,” she said. “It’s happening, really, seemingly overnight. And right around the corner… is physical AI where you have physical robots and the physical environment all operating and embodying AI in a physical world.”  

The AI Industrial Revolution, she says, marks a shift. Data is now simply raw material. Tokens are the new commodity—with NVIDIA serving as the token generator. Under the new paradigm: “You introduce data, the machine learns from that data, it builds models, and then it writes software that executes on a GPU,” Powell explained. “We call this the AI Factory.”  

AI factories are a new form of computing infrastructure, she said. “They’re purpose built to process raw data, refine them into models, and then produce tokens with great scale and efficiency.” Every company will produce digital intelligence through tokens, she said. Tokens, she defines, are “the intelligent response and actions of digital nurses or tutors or customer service agents, chip designers, even autonomous cars and weather prediction agents.”  

Clinical Trial Agents

In the clinical trials space, NVIDIA is advancing this vision through a partnership with IQVIA, “to accelerate their development and deployment of AI agents for their over 10,000 customers. IQVIA will use the NVIDIA AI Foundry service to build custom foundation models on its more than 64 petabytes of patient data, Powell reported. IQVIA is also developing agentic AI solutions, she added, outfitted with NIVIDA NIM microservices, specifically the Llama Nemotron models, NIVIDA AI Blueprints as reference workflows, and the Nemo platform on dedicated capacity of NVIDIA’s DGS Cloud.  

“This represents a significant leap forward in how we apply AI to healthcare and life sciences,” said Bhavik Patel, president of commercial solutions at IQVIA, in a press release. “We are excited to combine our industry-leading capabilities and decades of experience in artificial intelligence with NVIDIA’s advanced AI technologies to build new solutions powered by AI agents that are trained on world-class healthcare information and optimized for life science workflows. This collaboration will advance our mission to help our clients accelerate innovation and treatments to market.”  

Load more comments
comment-avatar